Clinical Trials Network: Long Island Regional Node

临床试验网络:长岛区域节点

基本信息

项目摘要

DESCRIPTION (provided by applicant): The Long Island Node of the CTN was established in 2000 out of the seeds of long-standing collaborations between the Principal Investigator and his colleagues with several community-based treatment programs in Manhattan, Queens and Long Island. Our goals are to contribute to the fundamental work of the CTN by collaborating in the conduct of rigorous multi-site clinical trials testing the effectiveness of new treatments for drug dependence and promoting the dissemination and adoption of treatments found to be effective, through a network of community-based treatment providers. Our vision includes promoting the culture of evidence- based practice based on principles of bi-directionality such that both researchers and community-based clinicians are considered equal collaborators in the clinical research enterprise. Over the initial funding period, members of the Long Island Node have: 1) Provided performance sites for 9 CTN clinical trials, and participated in two completed survey studies, 2) Led two CTN national clinical trials, now completed and in data analysis; 3) Participated and/or obtained funding for 14 ancillary or platform studies; 4) Assumed national leadership as Chair of the HIV Workgroup, the Common Assessment Battery Workgroup, the Training Subcommittee, the Data Management Subcommittee, the Dissemination Subcommittee, the Research Utilization Committee, the Task Force on Secondary Analysis, as well as memberships on the Operations Subcommittee, the Executive Committee, and numerous other committees, interest and work groups; 5) Co-Chaired the second annual Blending Conference (2002), authored or coauthored 26 papers and one book, and delivered over 60 symposia, presentations and trainings at professional meetings; and 6) Initiated and fostered training and dissemination efforts in Buprenorphine, Motivational Interviewing and Motivational Incentives. This application requests funding for 3 additional years to continue the ongoing activities begun during the initial funding period and to develop new research and dissemination initiatives both locally and nationally. We will complete participation of sites in 3 CTN trials currently active or in start-up (CTN-0028, CTN-0029, CTN-0030), continue publication of results and dissemination efforts for the two studies we have led (CTN- 0015, CTN-0019), contribute sites to new CTN trials, participate in protocol development teams for the new HIV screening protocol and other new protocols, and continue leadership, training, and dissemination efforts at the national and local levels. We will also continue to encourage and seek outside funding for studies conducted on the CTN platform.
描述(由申请人提供):CTN 的长岛节点成立于 2000 年,其根源在于首席研究员及其同事与曼哈顿、皇后区和长岛的多个社区治疗项目之间的长期合作。我们的目标是通过合作进行严格的多中心临床试验来测试药物依赖新疗法的有效性,并通过网络促进有效疗法的传播和采用,为 CTN 的基础工作做出贡献。以社区为基础的治疗提供者。我们的愿景包括促进基于双向原则的循证实践文化,使研究人员和社区临床医生都被视为临床研究企业中的平等合作者。在初始资助期间,长岛节点成员:1)为9项CTN临床试验提供了试验场地,并参与了两项已完成的调查研究;2)领导了两项CTN国家临床试验,现已完成并正在进行数据分析; 3)参与和/或获得14项辅助或平台研究的资助; 4) 担任艾滋病毒工作组、共同评估电池工作组、培训小组委员会、数据管理小组委员会、传播小组委员会、研究利用委员会、二次分析工作组主席以及运营小组成员,担任国家领导职务小组委员会、执行委员会以及众多其他委员会、兴趣小组和工作小组; 5) 共同主持了第二届年度混合会议(2002年),撰写或合着了26篇论文和一本书籍,并在专业会议上进行了60多次研讨会、演讲和培训; 6) 发起并促进丁丙诺啡、动机访谈和动机激励方面的培训和传播工作。该申请要求额外资助 3 年,以继续在初始资助期间开始的持续活动,并在当地和全国范围内开展新的研究和传播举措。我们将完成目前正在进行或正在启动的 3 项 CTN 试验(CTN-0028、CTN-0029、CTN-0030)中的中心参与,继续公布我们领导的两项研究的结果和传播工作(CTN-0015、 CTN-0019),为新的 CTN 试验贡献站点,参与新的 HIV 筛查方案和其他新方案的方案开发团队,并继续在国家和地方的领导、培训和传播工作水平。我们还将继续鼓励并寻求外部资助在CTN平台上进行的研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Edward V. Nunes其他文献

Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths.
以社区为基础的整群随机试验,以减少阿片类药物过量死亡。
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    158.5
  • 作者:
    Jeffrey H. Samet;N. El;T. J. Winhusen;Rebecca D Jackson;Emmanuel Oga;Redonna Chandler;Jennifer Villani;Bridget Freisthler;Joella W Adams;Arnie Aldridge;Angelo Angerame;Denise C. Babineau;Sarah M Bagley;Trevor Baker;Peter Balvanz;Carolina Barbosa;Joshua Barocas;Tracy A. Battaglia;Dacia D Beard;Donna Beers;Derek Blevins;Nicholas Bove;C. Bridden;Jennifer L Brown;Heather M. Bush;Joshua L. Bush;Ryan Caldwell;Katherine Calver;Deirdre Calvert;A. N. Campbell;Jane Carpenter;Rachel Caspar;Deborah Chassler;Joan Chaya;Debbie M. Cheng;Chinazo O Cunningham;Anindita Dasgupta;James L. David;Alissa Davis;Tammy Dean;M. Drainoni;Barry Eggleston;Laura C. Fanucchi;Daniel J. Feaster;Soledad Fernandez;Wilson Figueroa;Darcy A Freedman;Patricia R. Freeman;C. Freiermuth;Eric Friedlander;K. Gelberg;Erin B. Gibson;L. Gilbert;LaShawn Glasgow;Dawn A. Goddard;Stephen Gomori;Dawn E Gruss;Jennifer Gulley;Damara N. Gutnick;Megan E Hall;Nicole Harger Dykes;Sarah L. Hargrove;Kristin J. Harlow;Aumani Harris;Daniel R. Harris;Donald W Helme;JaNae Holloway;Juanita Hotchkiss;Terry Huang;Timothy R. Huerta;Timothy Hunt;A. Hyder;Van Ingram;Tim Ingram;Emily Kauffman;Jennifer L Kimball;Elizabeth N. Kinnard;Charles E. Knott;Hannah K. Knudsen;Michael W Konstan;Sarah Kosakowski;Marc R. Larochelle;Hannah M Leaver;Patricia A LeBaron;R. C. Lefebvre;Frances R Levin;Nikki Lewis;Nikki Lewis;Michelle R. Lofwall;David W. Lounsbury;Jamie E Luster;Michael S. Lyons;Aimee Mack;Katherine R. Marks;Stephanie Marquesano;Rachel Mauk;A. McAlearney;Kristin McConnell;Margaret L McGladrey;Jason McMullan;Jennifer Miles;Rosie Munoz Lopez;Alisha Nelson;Jessica L Neufeld;Lisa Newman;Trang Q Nguyen;Edward V. Nunes;Devin A Oller;Carrie B. Oser;Douglas R. Oyler;Sharon Pagnano;T. V. Parran;Joshua Powell;Kim Powers;William Ralston;Kelly Ramsey;Bruce D. Rapkin;Jennifer G Reynolds;Monica F. Roberts;Will Robertson;Peter Rock;Emma Rodgers;Sandra Rodriguez;Maria Rudorf;Shawn Ryan;Pamela Salsberry;Monika Salvage;Nasim Sabounchi;Merielle Saucier;Caroline Savitzky;Bruce Schackman;Elizabeth Schady;Eric E. Seiber;Aimee Shadwick;Abigail Shoben;Michael D Slater;S. Slavova;Drew Speer;Joel Sprunger;Laura E Starbird;Michele Staton;Michael D. Stein;D. Stevens;T. J. Stopka;A. Sullivan;Hilary L. Surratt;Rachel Sword Cruz;Jeffery C. Talbert;Jessica L Taylor;Katherine L Thompson;Nathan Vandergrift;Rachel Vickers;Deanna J Vietze;Daniel M. Walker;Alexander Y. Walley;Scott T Walters;Roger Weiss;Philip M. Westgate;E. Wu;April M Young;Gary A Zarkin;Sharon L. Walsh
  • 通讯作者:
    Sharon L. Walsh
Dissociative identity disorder and substance abuse: the forgotten relationship.
分离性身份障碍和药物滥用:被遗忘的关系。
  • DOI:
  • 发表时间:
    1999
  • 期刊:
  • 影响因子:
    2.8
  • 作者:
    David McDowell;Frances R. Levin;Edward V. Nunes
  • 通讯作者:
    Edward V. Nunes
Anger and depressive states among treatment-seeking drug abusers: testing the psychopharmacological specificity hypothesis.
寻求治疗的药物滥用者的愤怒和抑郁状态:检验精神药理学特异性假设。
  • DOI:
  • 发表时间:
    2001
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    E. Aharonovich;Hueco T. Nguyen;Edward V. Nunes
  • 通讯作者:
    Edward V. Nunes
Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design.
针对脾气暴躁和情绪不稳定的青少年的双丙戊酸治疗:双盲、安慰剂控制的交叉设计。
  • DOI:
  • 发表时间:
    2000
  • 期刊:
  • 影响因子:
    17.7
  • 作者:
    S. Donovan;Jonathan W. Stewart;Edward V. Nunes;F. Quitkin;Michael K. Parides;William Daniel;E. Susser;D. F. Klein
  • 通讯作者:
    D. F. Klein
Rapid Initiation of Injection Naltrexone for Opioid Use Disorder
快速开始注射纳曲酮治疗阿片类药物使用障碍
  • DOI:
    10.1001/jamanetworkopen.2024.9744
  • 发表时间:
    2024-05-01
  • 期刊:
  • 影响因子:
    13.8
  • 作者:
    Matisyahu Shulman;Miranda G Greiner;Hiwot M. Tafessu;Onumara Opara;Kaitlyn Ohrtman;Kenzie Potter;Kathryn Hefner;Eve Jelstrom;Richard N Rosenthal;K. Wenzel;Marc Fishman;John Rotrosen;Udi E. Ghitza;Edward V. Nunes;Adam Bisaga
  • 通讯作者:
    Adam Bisaga

Edward V. Nunes的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Edward V. Nunes', 18)}}的其他基金

NIDA Clinical Trials Network: New York Node
NIDA 临床试验网络:纽约节点
  • 批准号:
    10647100
  • 财政年份:
    2022
  • 资助金额:
    $ 125万
  • 项目类别:
NIDA Clinical Trials Network: Greater New York Node
NIDA 临床试验网络:大纽约节点
  • 批准号:
    9814170
  • 财政年份:
    2018
  • 资助金额:
    $ 125万
  • 项目类别:
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site
使用长效纳曲酮 (4/6) 哥伦比亚方案治疗站点的治疗研究
  • 批准号:
    7686108
  • 财政年份:
    2008
  • 资助金额:
    $ 125万
  • 项目类别:
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site
使用长效纳曲酮 (4/6) 哥伦比亚方案治疗站点的治疗研究
  • 批准号:
    8037045
  • 财政年份:
    2008
  • 资助金额:
    $ 125万
  • 项目类别:
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site
使用长效纳曲酮 (4/6) 哥伦比亚方案治疗站点的治疗研究
  • 批准号:
    7514307
  • 财政年份:
    2008
  • 资助金额:
    $ 125万
  • 项目类别:
New Approaches to Cocaine Abuse Medications
可卡因滥用药物的新方法
  • 批准号:
    7628364
  • 财政年份:
    2008
  • 资助金额:
    $ 125万
  • 项目类别:
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site
使用长效纳曲酮 (4/6) 哥伦比亚方案治疗站点的治疗研究
  • 批准号:
    8235961
  • 财政年份:
    2008
  • 资助金额:
    $ 125万
  • 项目类别:
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site
使用长效纳曲酮 (4/6) 哥伦比亚方案治疗站点的治疗研究
  • 批准号:
    8037045
  • 财政年份:
    2008
  • 资助金额:
    $ 125万
  • 项目类别:
Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site
使用长效纳曲酮 (4/6) 哥伦比亚方案治疗站点的治疗研究
  • 批准号:
    8437265
  • 财政年份:
    2008
  • 资助金额:
    $ 125万
  • 项目类别:
Drug Abuse Treatment Development and Research Mentoring
药物滥用治疗开发和研究指导
  • 批准号:
    7180794
  • 财政年份:
    2007
  • 资助金额:
    $ 125万
  • 项目类别:

相似国自然基金

基于创新扩散理论的广西农村校外青少年预防艾滋病互联网+健康教育干预研究
  • 批准号:
    71663013
  • 批准年份:
    2016
  • 资助金额:
    30.0 万元
  • 项目类别:
    地区科学基金项目
以中学生为核心贫困农村艾滋病、结核病及HIV/TB双重感染联合预防健康教育模式研究
  • 批准号:
    70773093
  • 批准年份:
    2007
  • 资助金额:
    23.0 万元
  • 项目类别:
    面上项目
贫困地区农村艾滋病综合预防管理及健康教育网络模式的研究
  • 批准号:
    70673078
  • 批准年份:
    2006
  • 资助金额:
    20.0 万元
  • 项目类别:
    面上项目

相似海外基金

RP1 Screen 2 Prevent
RP1 屏蔽 2 预防
  • 批准号:
    10595901
  • 财政年份:
    2023
  • 资助金额:
    $ 125万
  • 项目类别:
Penn Mental Health AIDS Research Center
宾夕法尼亚州心理健康艾滋病研究中心
  • 批准号:
    10819857
  • 财政年份:
    2023
  • 资助金额:
    $ 125万
  • 项目类别:
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM) Research Core & MHD-CE
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
  • 批准号:
    10686545
  • 财政年份:
    2023
  • 资助金额:
    $ 125万
  • 项目类别:
Screening strategies for sexually transmitted infections in a high HIV incidence setting in South Africa
南非艾滋病毒高发地区的性传播感染筛查策略
  • 批准号:
    10761853
  • 财政年份:
    2023
  • 资助金额:
    $ 125万
  • 项目类别:
Connecting Latinos en Pareja: A Couples-based HIV Prevention Intervention for Latino Male Couples
连接拉丁裔与帕雷哈:针对拉丁裔男性夫妇的基于夫妇的艾滋病毒预防干预措施
  • 批准号:
    10706860
  • 财政年份:
    2023
  • 资助金额:
    $ 125万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了